Abstract
Prolactin-secreting tumors are the most frequently encountered pituitary disorders in clinical practice. The realization that nearly 40% of so-called nonse- cretory and functionless pituitary tumors actually contain prolactin was an exciting one.1 This realization in conjunction with the development of a sensitive immunoassay for prolactin, the emergence of high-quality computed tomography (CT), and the discovery of dopamine agonist drugs has resulted
in a remarkably rapid growth in the understanding of prolactin-related disorders.
Keywords
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Peake GT, McKeel DW, Jarett L, et al: Ultrastructural, histologic and hormonal characterisation of a prolactin rich human pituitary tumour. J Clin Endocrinol Metab 29:1383, 1969.
Lloyd HM, Meares JD, Jacobi J: Effects of oestrogen and bromocriptine on in vivo secretion and mitosis in prolactin cells. Nature (Lond) 255:497, 1975.
Phelps C, Bartke A: Effect of chronic hyperprolactinemia on tuberoinfundibular dopaminergic neurons: Histofluorescence in male rats. In MacLeod RM, Thorner MO, Scapagnini U (eds): Prolactin. Basic and Clinical Correlates. Liviana, Padova, 1985, p. 615.
Franks S: Regulation of prolactin secretion by oestrogens: Physiological and pathological significance. Clin Sci 65:457, 1983.
Davis JRE, Selby C, Jeffcoate WJ: Oral contraceptive agents do not affect serum prolactin in normal women. Clin Endocrinol (Oxf) 20:427, 1984.
Weiner RI, Elias KA, Monnet F: The role of vascular changes in the etiology of prolactin secreting anterior pituitary tumors. In MacLeod RM, Thorner MO, Scapagnini U (eds): Prolactin: Basic and Clinical Correlates. Livana, Padova, 1985, p. 641.
Kovacs K, Korvath E, Cornblum B, et al: Pituitary chromophobe adenomas consisting of prolactin cells: A histologic, immunocytological and electron microscopic study. Virchows Arch [A] 366:113, 1975.
Kovacs K: Morphology of prolactin producing adenomas. Clin Endocrinol (Oxf) 6:71s, 1977.
Forbes AP, Henneman PH, Griswold GC, et al: Syndrome characterized by galactorrhea, amenorrhea and low urinary FSH: Comparison with acromegaly and normal lactation. J Clin Endocrinol Metab 14:265, 1954.
Frommel R: Uber puerpale Atrophie des Uterus. Z Geburtsh Gynakol 7:305, 1882.
Franks S, Murray MAF, Jequier AM, et al: Incidence and significance of hyperprolactinemia in women with amenorrhea. Clin Endocrinol (Oxf) 4:597, 1975.
Jacobs HW, Hull MGR, Murray MAF, et al: Therapy-oriented diagnosis of secondary amenorrhea. Horm Res 6:268, 1975.
Frantz AG, Kleinberg DL, Noel GL: Studies on prolactin in man. Recent Prog Horm Res 28:527, 1972.
Franks S, Nabarro JDN, Jacobs HS: Prevalence and presentation of hyperprolactinemia in patients with “functionless” pituitary tumors. Lancet 1:778, 1977.
Haesslein HC, Lamb EJ: Pituitary tumors in patients with secondary amenorrhea. Am J Obstet Gynecol 125:759, 1956.
Biller BJ, Boyd AE III, Moltich M, et al: Clinical features of pituitary tumors: Galactorrheasyndromes. In Post KD, Jackson IMD, Reichlin S (eds): Pituitary Adenoma Update. Plenum, New York, 1981, p. 65.
Besser GM, Wass JAH, Grossman A, et al: Clinical and therapeutic aspects of hyperprolactinemia. In MacLeod RM, Thorner MO, Scapagnini U (eds): Prolactin. Basic and Clinical Correlates. Liviana, Padova, 1985, p. 833.
Quigley ME, Sheehan KL, Casper RF, et al: Evidence for an increased opioid inhibition of luteinizing hormone secretion in hyperprolactinaemic patients with pituitary microadenoma. J Clin Endocrinol Metab 50:427, 1980.
Grossman A, Moult PJA, Mclntyre H, et al: Opiate mediation of amenorrhoea in hyperprolactinaemia and in weight-loss related amenorrhoea. Clin Endocrinol (Oxf) 17:379, 1982.
Thorner MO, Besser GM: Bromocriptine treatment of hyperprolactinemic hypogonadism, Acta Endocrinol (Suppl 216) (Copenh) 88:131, 1978.
Thorner MO: Prolactin. In Besser GM (ed): Clinics in Endocrinology and Metabolism. Vol. 6. WB Saunders, Philadelphia, 1977, p. 201.
Jacobs HS, Franks S, Murray MAF, et al: Clinical and endocrine features of hyperprolactinemic amenorrhea. Clin Endocrinol (Oxf) 5:439, 1976.
Molitch ME, Reichlin S: The amenorrhea, galactorrhea and hyperprolactinemia syndromes. In Stollerman GH (ed): Advances in Internal Medicine. Year Book Medical, Chicago, 1980, pp. 37–60.
Lavric MV: Breast secretion in nulligravid women. Am J Obstet Gynecol 112:1139, 1972.
Shevach AB, Spellacy WN: Galactorrhea and contraceptive practices. Obstet Gynecol 38:286, 1971.
Hardy J, Beauregard H, Robert F: Prolactin-secreting pituitary adenomas: Transsphenoidal microsurgical treatment. In Robyn C, Harter M (eds): Progress in Prolactin Physiology and Pathology. Elsevier, New York, 1978, p. 361.
Carter JN, Tyson JE, Tolis G, et al: Prolactin-secreting tumors and hypogonadism in 22 men. N Engl J Med 299:847, 1978.
Ambrosi B, Rosella B, Travaglini P, et al: Study of the effect of bromocriptine on sexual impotence. Clin Endocrinol (Oxf) 7:417, 1977.
Skrabanek P, McDonald D, deValera E, et al: Plasma prolactin in amenorrhea, infertility and other disorders: A retrospective study of 608 patients. Ir J Med Sci 149:236, 1980.
Spark RF, White RA, Connolly PB: Impotence is not always psychogenic. JAMA 243:750, 1980.
Segal S, Yaffee H, Laufer N, et al: Male hyperprolactinemia: Effects on fertility. Fertil Steril 32:556, 1979.
Boyd AE III, Hamilton D, Murray BG, et al: Medical management of prolactinomas. II. In Black PM, Zervas NT, Ridgway EC, et al (eds): Secretory Tumors of the Pituitary Gland. Progress in Endocrine Research and Therapy. Vol 1. Raven, New York, 1984, p. 65.
Thorner MO, Edwards CRW, Hanker JP, et al: Prolactin and gonadotropin interaction in the male. In Troen P, Nankin H (eds): The Testis in Normal and Infertile Men. Raven, New York, 1977, pp. 351–366.
Kleinberg DL, Noel GL, Frantz AG: Galactorrhea: 235 cases including 48 with pituitary tumors. N Engl J Med 296:589, 1977.
Bassi F, Guisti G, Borsi L, et al: Plasma androgens in women with hyperprolactinemic amenorrhea. Clin Endocrinol (Oxf) 5:61, 1977.
Molitch ME, Reichlin S: Hypothalamic hyperprolactinemia: Neuroendocrine regulation of prolactin secretion in patients with lesions of the hypothalamus and pituitary stalk. In MacLeod RM, Thorner MO, Scapagnini U (eds): Prolactin. Basic and Clinical Correlates. Liviana, Padova, 1985, p. 709.
Johnston DG, Haigh J, Prescott RWG, et al: Prolactin secretion and biological activity in females with galactorrhoea and normal circulating prolactin concentrations at rest. Clin Endocrinol (Oxf) 22:661, 1985.
VanWyk JJ, Grumbach MM: Syndrome of precocious menstuation and galactorrhea in juvenile hypothyroidism. An example of hormonal overlap in pituitary feedback. J Pediatr 57:416, 1960.
Honbo KS, Van herle AJ, Kellett KA, et al: Serum prolactin levels in untreated primary hypothyroidism. Am J Med 64:782, 1978.
Contreras P, Generini G, Michelsen H, et al: Hyperprolactinemia and galactorrhea: Spontaneous versus iatrogenic hypothyroidism. J Clin Endocrinol Metab 53:1036, 1981.
Kapcala LP: Galactorrhea and thyrotoxicosis. Arch Intern Med 144:2349, 1984.
Tourniaire J, Trouillas J, Chalendar D, et al: Somatotropic adenoma manifested by galactorrhea without acromegaly. J Clin Endocrinol Metab 61:451, 1985.
Taylor S: High resolution computed tomography of the sella. Radiol Clin North Am 20:207, 1982.
Wolpert SM: The radiology of pituitary adenomas. Semin Roentgenol 19:53, 1984.
Gardeur D, Naidich TP, Metzger J: CT analysis of intrasellar pituitary adenomas with emphasis on patterns of contrast enhancement. Neuroradiology 20:241, 1981.
Hsu T-H, Shapiro JR, Tyson JE, et al: Hyperprolactinemia associated with empty sella syndrome. JAMA 235:2002, 1976.
Badawy SZA, Nusbaum ML, Omar M: Hypothalamic-pituitary evaluation in patients with galactorrhea-amenorrhea and hyperprolactinemia. Obstet Gynecol 55:1, 1980.
Gharib H, Frey HM, Laws ER Jr, et al: Coexistent primary empty sella syndrome and hyperprolactinemia: Report of 11 cases. Arch Intern Med 143:1383, 1983.
Haney AF, Kramer RS, Wiebe RH, et al: Hypothalamic-pituitary function and radiographic evaluation of women with hyperprolactinemia and an empty sella turcica. Am J Obstet Gynecol 134:917, 1979.
Futterweit W: Galactorrhea, amenorrhea, hyperprolactinemia and pseudotumor cerebri in a patient with primary empty sella syndrome: Case report with review of the literature. Mt Sinai J Med 49:514, 1982.
Dominque JN, Wing SD, Wilson CB: Coexisting pituitary adenomas and partially empty sellas. J Neurosurg 48:23 ,1978.
Swanson JA, Sherman BM, Van Gilder JC, et al: Coexistent empty sella and prolactinsecreting microadenoma. Obstet Gynecol 53:258, 1979.
Archer DF, Maroon JC, DuBois PJ: Galactorrhea, amenorrhea, hyperprolactinemia, and an empty sella. Obstet Gynecol 52(Suppl):23, 1978.
Jones JR, DeHempel PAC, Kemmann E, et al: Galactorrhea and amenorrhea in a patient with an empty sella. Obstet Gynecol 49:S9, 1977.
Gomez F, Reyes F, Faiman C: Nonpuerperal galactorrhea and hyperprolactinemia. Am J Med 62:648, 1977.
Archer DF, Spring JW, Nankin HR, et al: Pituitary and gonadotrophin response in women with idiopathic hyperprolactinemia. Fertil Steril 27:1158, 1976.
Aono T, Myake T, Shiroji T, et al: Impaired LH release following exogenous estrogen administration in patients with amenorrhea-galactorrhea syndrome. J Clin Endocrinol Metab 42:696, 1976.
Mortimer CH, Besser GH, McNeilly AD, et al: Luteinizing hormone and follicle stimulating hormone releasing hormone test in patients with hypothalamic pituitary gonadal dysfunction. Br Med J 4:73, 1973.
Wiebe RH, Hammond CB, Borchert LG: Diagnosis of prolactin-secreting pituitary microadenoma. Am J Obstet Gynecol 126:993, 1976.
Lackelin GCL, Abu-Fadil S, Yen SSC: Functional delineation of hyperprolactinemic amenorrhea. J Clin Endocrinol Metab 44:1163, 1977.
Van Campenhout J, Papas S, Blanchet P: Pituitary responses to synthetic luteinizing hormone-releasing hormone in thirty-four cases of amenorrhea or oligo-amenorrhea associated with galactorrhea. Am] Obstet Gynecol 127:723, 1977.
Zarate Z, Jacobs LS, Canales ES: Functional evaluation of pituitary reserve in patients with the amenorrhea-galactorrhea syndrome utilizing luteinizing releasing hormone (LH-RH), L-dopa and chlorpromazine. J Clin Endocrinol Metab 37:855, 1973.
Chang RJ, Keye WR, Young JR, et al: Detection, evaluation and treatment of pituitary microadenomas in patients with galactorrhea and amenorrhea. Am J Obstet Gynecol 128:357, 1977.
Lamberts SWJ, Birkenhäger JC, Kwa HG: Basal and TRH-stimulated prolactin in patients with pituitary tumours. Clin Endocrinol (Oxf) 5:709, 1976.
Barbarino A, de Marinis L, Menini E, et al: Prolactin-secreting pituitary adenomas: Prolactin dynamics before and after transsphenoidal surgery. Acta Endocrinol (Kbh) 91:397, 1979.
Cowden EA, Ratcliffe JG, Thomson JA, et al: Tests of prolactin secretion in diagnosis of prolactinomas. Lancet 1:1155, 1979.
Healy DL, Pepperell RJ, Stockdale J, et al: Pituitary autonomy in hyperprolactinemic secondary amenorrhea: Results of hypothalamic-pituitary testing. J Clin Endocrinol Metab 44:809, 1977.
Jeske W: The effect of metoclopramide, TRH and L-dopa on prolactin secretion in pituitary adenoma and in “functional” galactorrheoea syndrome. Acta Endocrinol (Kbh) 91:385, 1979.
Schlechte JA, Sherman BM: Abnormal regulation of prolactin secretion after successful surgery for prolactin-secreting pituitary tumours. Clin Endocrinol (Oxf) 15:165, 1981.
Frantz AG: Endocrine diagnosis of prolactin-secreting pituitary tumors. In Black PM, Zervas NT, Ridgway EC, et al. (eds): Secretory Tumors of the Pituitary Gland. Progress in Endocrine Research and Therapy. Vol 1. Raven, New York, 1984, p. 45.
Fine SA, Frohman LA: Loss of central nervous system component of dopaminergic inhibition of prolactin secretion in patients with prolactin secreting pituitary tumors. J Clin Invest 61:973, 1978.
Crosignani PG, Ferrari C, Malinverni A, et al: Effect of central nervous system dopaminergic activation on prolactin secretion in man: Evidence for a common central defect in hyperprolactinemic patients with and without radiological signs of pituitary tumors. J Clin Endocrinol Metab 51:1068, 1980.
Genazzani ZR, De Leo V, Murru S, et al: Dynamic tests of prolactin secretion in hyperprolactinemic states: Carbidopa-L-dopa and indirectly acting dopamine agonists. J Clin Endocrinol Metab 54:429, 1982.
Moriondo P, Travaglini P, Nisim M, et al: Evaluation of two inhibitory tests (nomifensine and L-dopa + carbidopa) for the diagnosis of hyperprolactinaemic states. Clin Endicrinol (Oxf) 13:525, 1980.
Muller EE, Genazzani AR, Murru S: Nomifensine: diagnostic test in hyperprolactinemic states. J Clin Endocrinol Metab 47:1352, 1978.
Ferrari C, Crosignani PG, Caldara MC, et al: Failure of nomifensine administration to discriminate between tumorous and nontumorous hyperprolactinemia. J Clin Endocrinol Metab 50:23, 1979.
Kamoi K, Tchuchida I, Sato H, et al: Comparison of the responses in the nomifensine test with hyperprolactinemia due to prolactin-secreting pituitary tumors and nonprolactin-secreting hypothalamic tumors. J Clin Endocrinol Metab 53:1285, 1981.
Camanni F, Genazzani AR, Massara F, et al: Prolactin responsiveness to nomifensine in patients with hyperprolactinemia of tumorous or uncertain etiology. J Clin Endocrinol Metab 51:650, 1980.
Dallabonzana D, Spelta B, Botalla L, et al: Effects of nomifensine on growth hormone and prolactin secretion in normal subjects and in pathological hyperprolactinemia. J Clin Endocrinol Metab 54:1125, 1982.
Martin TL, Kim M, Malarkey WB: The natural history of idiopathic hyperprolactinemia. / Clin Endocrinol Metab 60:855, 1985.
Malarkey WB, Martin TL, Kim M: Patients with idiopathic hyperprolactinemia infrequently develop pituitary tumors. In MacLeod RM, Throner MO, Scapagnini U (eds): Prolactin. Basic and Clinical Correlates. Liviana, Padova, 1985, p. 705.
Jackson RD, Wortsman J, Malarkey WB: Characterization of a large molecular weight prolactin in women with idiopathic hyperprolactinemia and normal menses. J Clin Endocrinol Metab 61:258, 1985.
Post KD, Kasdon DL: Sellar and parasellar lesions mimicking adenoma. In Post KD, Jackson I, Reichlin S, et al. (eds): The Pituitary Adenoma. Plenum, New York, 1980, p. 159.
Stuart CA, Neelon FA, Lebovitz HE: Hypothalamic insufficiency: The cause of hypopituitarism in sarcoidosis. Ann Intern Med 88:589, 1978.
Vesely DL, Maldonodo A, Levey GS: Partial hypopituitarism and possible hypothalamic involvement in sarcoidosis: Report of a case and review of the literature. Am J Med 62:425, 1977.
Asa SL, Bilbao JM, Kovacs K, et al: Lymphocytic hypophysitis of pregnancy resulting in hypopituitarism: A distinct clinicopathologic entity. Ann Intern Med 95:166, 1981.
Mayfield RK, Levine JH, Gordon L, et al: Lymphoid adenohypophysitis presenting as a pituitary tumor. Am J Med 69:619, 1980.
Rickards AG, Harvey PW: Giant cell granuloma and the other pituitary granulomata. Q J Med 23:425, 1954.
Hoick S, Laursen H: Prolactinoma coexistent with granulomatous hypophysitis. Acta Neuropathol (Berl) 61:253, 1983.
Abrams HL, Spiro R, Goldstein N: Metastases in carcinoma: Analysis of 1000 autopsied cases. Cancer 3:74, 1950.
Hagerstrand I, Schonebeck J: Metastases to the pituitary gland. Acta Pathol Microbiol Scand 75:64, 1969.
Kovacs K: Metastatic cancer of the pituitary gland. Oncology 27:533, 1973.
Teears RJ, Silverman EM: Clinicopathologic review of 88 cases of carcinoma metastatic to the pituitary gland. Cancer 36:216, 1975.
Stacpoole PW, Kandell TW, Fisher WR: Primary empty sella, hyperprolactinemia and isolated ACTH deficiency after postpartum hemorrhage. Am J Med 74:905, 1983.
Merker E, Futterweit W: Postpartum amenorrhea, diabetes insipidus and galactorrhea. Am J Med 56:554, 1974.
Dadey SL, Hurxthal LM: Abnormal lactation: Report of a case with amenorrhea and diabetes insipidus. Lahey Clin Bull 10:166, 1957.
Boyd AE III, Reichlin S, Turksoy RN: Galactorrhea-amenorrhea syndrome: Diagnosis and therapy. Ann Intern Med 87:165, 1977.
Maas JM: Amenorrhea-galactorrhea syndrome: Before, during and after pregnancy. Fertil Steril 18:857, 1967.
Koppelman MCS, Jaffe MJ, Rieth KG, et al: Hyperprolactinemia, amenorrhea, and galactorrhea: A retrospective assessment of twenty-five cases. Ann Intern Med 100:115, 1984.
Weiss MH, Teal J, Gott P, et al: Natural history of microprolactinomas: Six-year follow-up. Neurosurgery 12:180, 1983.
March CM, Kletzky OA, Davajan V, et al: Longitudinal evaluation of patients with untreated prolactin-secreting pituitary adenomas. Am J Obstet Gynecol 139:835, 1981.
Besser GM, Parke L, Edwards CRW, et al: Galactorrhoea: Successful treatment with reduction of plasma prolactin levels by bromergocryptine. Br Med J 3:669, 1972.
Yuen BH: Bromocriptine, pituitary tumours and pregnancy. Lancet 2:1314, 1978.
Thorner MO, Evans WS, MacLeod RM, et al: Hyperprolactinemia: Current concepts of management including medical therapy with bromocriptine. Adv Biochem Psychopharmacol 23:165, 1980.
Parkes D: Drug therapy: Bromocryptine. N Engl] Med 301:873, 1979.
Nagulesparen M, Ang V, Jenkins JS: Bromocriptine treatment of males with pituitary tumors, hyperprolactinaemia, and hypogonadism. Clin Endocrinol (Oxf) 9:73, 1978.
Mroueh AM, Siler-Khodr TM: Bromocriptine therapy in cases of amenorrhea-galactorrhea. Am J Obstet Gynecol 127:291, 1977.
Fluckiger E: Pharmacology of prolactin secretion. In Falbusch R, et al (eds): Treatment of Pituitary Adenomas. Little, Brown, Boston, 1978, p. 351.
Aronoff SL, Daughaday WH, Laws ER Jr: Bromocriptine treatment of prolactinomas. (Letter.) N Engl J Med 300:1391, 1979.
Besser GM, Mouk PJA: Prolactinomas and their management. In Jacobs HS (ed): Advances in Gynecological Endocrinology. 6th ed. London Royal College of Obstetricians and Gynecologists, London, 1978, p. 234.
Barrow DL, Tindall GT, Kovacs K, et al: Clinical and pathological effects of bromocriptine on prolactin-secreting and other pituitary tumors. J Neurosurg 60:1, 1984.
Bergh T, Nillius SJ, Wide L: Bromocriptine treatment of seven women with primary amenorrhea and prolactin-secreting pituitary tumors. Clin Endocrinol (Oxf) 10:145, 1979.
Vance ML, Evans WS, Thorner MO: Drugs five years later: Bromocriptine. Ann Intern Med 100:78, 1983.
Velentzas C, Carras D, Vassilouthis J: Regression of pituitary prolactinoma with bromocriptine administration. JAMA 245:1149, 1981.
Tindall GT, Kovacs K, Horvath E, et al: Human prolactin-producing adenomas and bromocriptine: A histological, immunocytochemical, ultrastructural, and morphometric study. J Clin Endocrinol Metab 55:1178, 1982.
Thorner MO, Schran HF, Evans WS, et al: A broad spectrum of prolactin suppression by bromocriptine in hyperprolactinemic women: A study of serum prolactin and bromocriptine levels after acute and chronic administraiton of bromocriptine. J Clin Endocrinol Metab 50:1026, 1980.
Thorner MO, Edwards CRW, Charlesworth M, et al: Pregnancy in patients presenting with hyperprolactinaemia. Br Med J 2:771, 1979.
Thorner MO, Besser GM: Bromocriptine treatment of hyperprolactinaemic hypogonadism. Acta Endocrinol (Copenh) [Suppl 216] 88:131, 1978.
Wass JAH, Moult PJA, Thorner MO, et al: Reduction of pituitary tumor size in patients with prolactinomas and acromegaly treated with bromocriptine with or without radiotherapy. Lancet 2:66, 1979.
Wass JAH, Williams J, Charlesworth M, et al: Bromocriptine in management of large pituitary tumors. Br Med J 284:1908, 1982.
Clayton RN, Webb J, Heath DA, et al: Dramatic and rapid shrinkage of a massive invasive prolactinoma with bromocriptine: A case report. Clin Endocrinol (Oxf) 22:573, 1985.
Chiodini P, Liuzzi A, Cozzi R, et al: Size reduction of macroprolactinomas by bromocriptine or lisguride treatment. J Clin Endocrinol Metab 53:737, 1981.
George SR, Burrow GN, Zinman B, et al: Regression of pituitary tumors, a possible effect of bromergocryptine. Am J Med 66:697, 1979.
Grisoli F, Vincentelli F, Jaquet P, et al: Prolactin secreting adenomas in 22 men. Surg Neurol 13:241, 1980.
McGregor AM, Scanlon MF, Hall K, et al: Reduction in size of a pituitary tumor by bromocriptine therapy. N Engl J Med 300:291, 1979.
Vaidya RA, Aloorkar SD, Rege NR: Normalization of visual fields following bromocriptine treatment in hyperprolactinemic patients with visual field constriction. Fertil Steril 29:632, 1978.
Thorner MO, Martin WH, Rogol AD, et al: Rapid regression of pituitary prolactinomas during bromocriptine treatment. J Clin Endocrinol Metab 51:438, 1980.
Thorner MO, Perryman RL, Rogol AD, et al: Rapid changes of prolactinoma volume after withdrawal and reinstitution of bromocriptine. J Clin Endocrinol Metab 153:480, 1981.
Wollesen FO, Andersen T, Karle A: Size reduction of extrasellar pituitary tumors during bromcriptine treatment: Quantitation of effect on different types of tumors. Ann Intern Med 96:281, 1982.
Nillius SJ, Bergh T, Lundberg PO, et al: Regression of a prolactin-secreting pituitary tumor during long-term treatment with bromocriptine. Fertil Steril 30:710, 1978.
Landolt AM, Wutrich R, Fellmann H: Regression of pituitary prolactinoma after treatment with bromocriptine. Lancet 1:1082, 1979.
Corenblum B, Webster BR, Mortimer CB, et al: Possible antitumor effects of 2-bromoergocryptine (CB-154 Sandoz) in 2 patients with large prolactin-secreting pituitary adenomas. Clin Res 23:614A, 1975.
Nabarro JDN: Pituitary prolactinomas. Clin Endocrinol (Oxf) 17:129, 1982.
MacLeod RM, Lehmeyer JE: Studies on the mechanism of the dopamine-mediated inhibition of prolactin secretion. Endocrinology 94:1077, 1974.
Mashiter K, Adams E, Bear M, et al: Bromocriptine inhibits prolactin and growth-hormone release by human pituitary tumours in culture. Lancet 2:197, 1977.
Sobrinho LG, Nunes MC, Calhaz-Jorge C, et al: Effect of treatment with bromocriptine on the size and activity of prolactin-producing pituitary tumors. Acta Endocrinol (Copenh) 96:24, 1981.
Eversmann T, Fahlbusch R, Rjosk HK, et al: Persisting suppression of prolactin secretion after long-term treatment with bromocriptine in patients with prolactinomas. Acta Endocrinol (Copenh) 92:413, 1979.
Grossman A, Bouloux P-MG, Loneragan R, et al: Comparison of the clinical activity of mesulergine and pergolide in the treatment of hyperprolactinaemia. Clin Endocrinol (Oxf) 22:611, 1985.
Kleinberg DL, Lieberman A, Todd J, et al: Pergolide mesylate: A potent day-long inhibitor of prolactin in rhesus monkeys and patients with Parkinson’s disease. J Clin Endocrinol Metab 51:152, 1980.
Franks S, Horrocks PM, Lynch SS, et al: Effectiveness of pergolide mesylate in long term treatment of hyperprolactinaemia. Br Med J 286:1177, 1983.
Kleinberg DL, Boyd AE III, Wardlaw S, et al: Treatment of prolactin and growth hormone secreting pituitary tumors with pergolide. N Engl J Med 309:704, 1983.
Hardy J, Beauregard H, Robert F: Prolactin-secreting adenomas: Transsphenoidal microsurgical treatment. In Robyn C, et al (eds): Progress in Prolactin Physiology and Pathology. Elsevier/North-Holland, New York, 1978, p. 361.
Hardy J: Transsphenoidal surgery of hypersecreting pituitary tumors. In Kohler PO, Ross GT (eds): Diagnosis and Treatment of Pituitary Tumors. Excerpta Medica, Amsterdam, 1973, p. 179.
Hardy J: Transsphenoidal microsurgical removal of pituitary microadenoma. In Krayenbühl H, Maspes PE, Sweet WH (eds): Progress in Neurological Surgery. S. Karger, Basel, 1975, p. 200.
Hardy J, Vezina JL: Transsphenoidal neurosurgery of intracranial neoplasm. In Thompson RA, Greene JR (eds): Advances in Neurology. Raven Press, New York, 1976, p. 261.
Hardy J: Microsurgical exploration of a normal sella turcia for a microadenoma. In Derome JP, Jedynak CP, Peillon F (eds): Pituitary Adenomas: Biology, Physiopathology and Treatment. Asclepios, France, 1980, p. 195.
Hardy J (ed): Prolactinoma. Neurochirurgie 27(Suppl 1), 1981.
Chang RJ, Keye WR Jr, Young JR: Detection, evaluation, and treatment of pituitary microadenomas in patients with galactorrhea and amenorrhea. Am J Obstet Gynecol 128:356, 1977.
Jacques P, Grisoli F, Guibout M, et al: Prolactin secreting tumors: Endocrine status before and after surgery in 33 women. J Clin Endocrinol Metab 46:459, 1978.
Tucker H St G, Grubb SR, Wigand JP, et al: Galactorrhea-amenorrhea syndrome: Follow-up of forty five patients after pituitary tumor removal. Ann Intern Med 94:302, 1981.
Post KD, Biller BJ, Adelman LS, et al: Selective transsphenoidal adenomectomy in women with galactorrhea-amenorrhea. JAMA 242:158, 1979.
Tindall GT, McLanahan S, Christy JH: Transsphenoidal microsurgery for pituitary tumors associated with hyperprolactinemia. J Neurosurg 48:849, 1978.
Wilson Ch.B, Dempsey SC: Transsphenoidal microsurgical removal of 250 pituitary adenomas. J Neurosurg 48:13, 1978.
Domingue JN, Richmond IL, Wilson CB: Results of surgery in 114 patients with prolactinsecreting pituitary adenomas. Am J Obstet Gynecol 137:102, 1980.
Faria MA Jr, Tindall GT: Transsphenoidal microsurgery for prolactinomas. In Givens Jr (ed): Hormone Secreting Pituitary Tumors. Year Book, Chicago, 1982, p. 275.
Hardy J: Transsphenoidal microsurgery of prolactinomas. In Black P McL, et al. (eds): Progress in Endocrine Research and Therapy. Vol. 1. Raven Press, New York, 1984, p. 73.
Serri O, Rasio E, Beauregard H, et al: Recurrence of hyperprolactinemia after selective transsphenoidal adenomectomy in women with prolactinoma. N Engl] Med 309:280, 1983.
Rodman EF, Molitch ME, Post KD, et al: Long-term follow-up of transsphenoidal selective adenomectomy for prolactinoma. JAMA 252:921, 1984.
Antunes JL, Housepian EM, Frantz AG, et al: Prolactin-secreting pituitary tumors. Ann Neurol 2:148, 1977.
Sheline GE, Grossman A, Jones AE, et al: Radiation therapy for prolactinomas. In Black P McL, et al. (eds): Secretory Tumors of the Pituitary Gland. Progress in Endocrine Research and Therapy. Vol. 1. Raven Press, New York, 1984, p. 93.
Grossman A, Cohen BL, Charlesworth M, et al: The circulating prolactin response to radiotherapy in patients with prolactinoma. Br Med J 288:1105, 1984.
Grossman A, Besser GM: Prolactinomas. Br Med J 290:182, 1985.
Robinson AG, Nelson PB: Prolactinomas in women: Current therapies. Ann Intern Med 99:115, 1983.
Turkalj I, Braun P, Krupp P: Surveillance of bromocriptine in pregnancy. JAMA 247:1589, 1982.
Lamberts SWJ, Klijn JGM, deLange SA, et al: The incidence of complications during pregnancy after treatment of hyperprolactinemia with bromocriptine in patients with radiologically evident pituitary tumors. Fertil Steril 31:614, 1979.
Griffith RW, Turkalj I, Braun P: Pituitary tumors during pregnancy in mothers treated with bromocriptine. Br J Clin Pharmacol 1:393, 1979.
Gemzell C, Wang CF: Outcome of pregnancy in women with pituitary adenoma. Fertil Steril 31:363, 1979.
Molitch ME, Elton RL, Blackwell RE, et al: Bromocriptine as primary therapy for prolactinsecreting macroadenomas: Results of a prospective multicenter study. J Clin Endocrinol Metab 60:698, 1985.
Warfield A, Finkel DM, Schatz NJ, et al: Bromocriptine treatment of prolactin-secreting pituitary adenomas may restore pituitary function. Ann Intern Med 101:783, 1984.
Johnston DG, Prescott RWG, Kendall-Taylor P, et al: Hyperprolactinemia. Long-term effects of bromocriptine. Am J Med 75:868, 1983.
Spark RF, Baker R, Bienfang DC, et al: Bromocriptine reduces pituitary tumor size and hypersecretion. JAMA 247:311, 1982.
Molitch ME: Pregnancy and the hyperprolactinemic woman. N Engl J Med 312:1364, 1985.
Barbieri RL, Ryan KJ: Bromocriptine: Endocrine pharmacology and therapeutic applications. Fertil Steril 39:727, 1983.
Adelman LS: The Pathology of Pituitary Adenomas. In Post KD, Jackson IM, Reichlin S (eds): The Pituitary Adenoma ,Plenum Press, New York, 1980, pp. 47–62.
Wolpert SM: The Radiology of Pituitary Adenomas. In Post KD, Jackson IM, Reichlin S (eds): The Pituitary Adenoma ,Plenum Press, New York, 1980, pp. 297–320.
Post KD, Kasdon DL: Sellar and Parasellar Lesions Mimicking Adenoma. In Post KD, Jackson IM, Reichlin S (eds): The Pituitary Adenoma ,Plenum Press, New York, 1980, pp. 159–216.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 1987 Plenum Publishing Corporation
About this chapter
Cite this chapter
Kannan, C.R. (1987). Prolactin-Secreting Tumors. In: The Pituitary Gland. Clinical Surveys in Endocrinology, vol 1. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-1849-1_14
Download citation
DOI: https://doi.org/10.1007/978-1-4613-1849-1_14
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4612-9032-2
Online ISBN: 978-1-4613-1849-1
eBook Packages: Springer Book Archive